 Genetic Technologies Limited ASX: GTG; NASDAQ: GENE the Company has developed a detailed implementation plan to enable a temporary transition of our genetic testing laboratory to a high-throughput COVID-19 testing laboratory, should it be required by Government agencies to assist with demand. Initial work to identify laboratory workflows, instrument modification, laboratory compliance for biologics and contaminated materials handling has commenced. This COVID-19 testing implementation plan has been developed as a result of the Companys expectation of an increase in demand for COVID-19 testing and is not based on any existing agreement to provide COVID-19 testing. 